Report Detail

Pharma & Healthcare Global SARS-CoV-2 IgG(RBD) ELISA Market Size, Status and Forecast 2021-2027

  • RnM4303191
  • |
  • 10 April, 2021
  • |
  • Global
  • |
  • 105 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global SARS-CoV-2 IgG(RBD) ELISA Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 ELISA Sets
    • 1.2.3 ELISA Kits
  • 1.3 Market by Application
    • 1.3.1 Global SARS-CoV-2 IgG(RBD) ELISA Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospital
    • 1.3.3 Clinic
    • 1.3.4 Disease control and prevention system
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global SARS-CoV-2 IgG(RBD) ELISA Market Perspective (2016-2027)
  • 2.2 SARS-CoV-2 IgG(RBD) ELISA Growth Trends by Regions
    • 2.2.1 SARS-CoV-2 IgG(RBD) ELISA Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 SARS-CoV-2 IgG(RBD) ELISA Historic Market Share by Regions (2016-2021)
    • 2.2.3 SARS-CoV-2 IgG(RBD) ELISA Forecasted Market Size by Regions (2022-2027)
  • 2.3 SARS-CoV-2 IgG(RBD) ELISA Industry Dynamic
    • 2.3.1 SARS-CoV-2 IgG(RBD) ELISA Market Trends
    • 2.3.2 SARS-CoV-2 IgG(RBD) ELISA Market Drivers
    • 2.3.3 SARS-CoV-2 IgG(RBD) ELISA Market Challenges
    • 2.3.4 SARS-CoV-2 IgG(RBD) ELISA Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top SARS-CoV-2 IgG(RBD) ELISA Players by Revenue
    • 3.1.1 Global Top SARS-CoV-2 IgG(RBD) ELISA Players by Revenue (2016-2021)
    • 3.1.2 Global SARS-CoV-2 IgG(RBD) ELISA Revenue Market Share by Players (2016-2021)
  • 3.2 Global SARS-CoV-2 IgG(RBD) ELISA Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by SARS-CoV-2 IgG(RBD) ELISA Revenue
  • 3.4 Global SARS-CoV-2 IgG(RBD) ELISA Market Concentration Ratio
    • 3.4.1 Global SARS-CoV-2 IgG(RBD) ELISA Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by SARS-CoV-2 IgG(RBD) ELISA Revenue in 2020
  • 3.5 SARS-CoV-2 IgG(RBD) ELISA Key Players Head office and Area Served
  • 3.6 Key Players SARS-CoV-2 IgG(RBD) ELISA Product Solution and Service
  • 3.7 Date of Enter into SARS-CoV-2 IgG(RBD) ELISA Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 SARS-CoV-2 IgG(RBD) ELISA Breakdown Data by Type

  • 4.1 Global SARS-CoV-2 IgG(RBD) ELISA Historic Market Size by Type (2016-2021)
  • 4.2 Global SARS-CoV-2 IgG(RBD) ELISA Forecasted Market Size by Type (2022-2027)

5 SARS-CoV-2 IgG(RBD) ELISA Breakdown Data by Application

  • 5.1 Global SARS-CoV-2 IgG(RBD) ELISA Historic Market Size by Application (2016-2021)
  • 5.2 Global SARS-CoV-2 IgG(RBD) ELISA Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America SARS-CoV-2 IgG(RBD) ELISA Market Size (2016-2027)
  • 6.2 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type
    • 6.2.1 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2021)
    • 6.2.2 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2022-2027)
    • 6.2.3 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2027)
  • 6.3 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application
    • 6.3.1 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2021)
    • 6.3.2 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2022-2027)
    • 6.3.3 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2027)
  • 6.4 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Country
    • 6.4.1 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2016-2021)
    • 6.4.2 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size (2016-2027)
  • 7.2 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Type
    • 7.2.1 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2021)
    • 7.2.2 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2022-2027)
    • 7.2.3 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2027)
  • 7.3 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Application
    • 7.3.1 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2021)
    • 7.3.2 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2022-2027)
    • 7.3.3 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2027)
  • 7.4 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Country
    • 7.4.1 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2016-2021)
    • 7.4.2 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size (2016-2027)
  • 8.2 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Type
    • 8.2.1 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Application
    • 8.3.1 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Region
    • 8.4.1 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size (2016-2027)
  • 9.2 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type
    • 9.2.1 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2021)
    • 9.2.2 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2022-2027)
    • 9.2.3 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2027)
  • 9.3 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application
    • 9.3.1 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2021)
    • 9.3.2 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2022-2027)
    • 9.3.3 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2027)
  • 9.4 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Country
    • 9.4.1 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2016-2021)
    • 9.4.2 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size (2016-2027)
  • 10.2 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Type
    • 10.2.1 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Application
    • 10.3.1 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Country
    • 10.4.1 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 R&D Systems
    • 11.1.1 R&D Systems Company Details
    • 11.1.2 R&D Systems Business Overview
    • 11.1.3 R&D Systems SARS-CoV-2 IgG(RBD) ELISA Introduction
    • 11.1.4 R&D Systems Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
    • 11.1.5 R&D Systems Recent Development
  • 11.2 Thermo Fisher Scientific
    • 11.2.1 Thermo Fisher Scientific Company Details
    • 11.2.2 Thermo Fisher Scientific Business Overview
    • 11.2.3 Thermo Fisher Scientific SARS-CoV-2 IgG(RBD) ELISA Introduction
    • 11.2.4 Thermo Fisher Scientific Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
    • 11.2.5 Thermo Fisher Scientific Recent Development
  • 11.3 Ortho Clinical Diagnostics
    • 11.3.1 Ortho Clinical Diagnostics Company Details
    • 11.3.2 Ortho Clinical Diagnostics Business Overview
    • 11.3.3 Ortho Clinical Diagnostics SARS-CoV-2 IgG(RBD) ELISA Introduction
    • 11.3.4 Ortho Clinical Diagnostics Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
    • 11.3.5 Ortho Clinical Diagnostics Recent Development
  • 11.4 BD Biosciences
    • 11.4.1 BD Biosciences Company Details
    • 11.4.2 BD Biosciences Business Overview
    • 11.4.3 BD Biosciences SARS-CoV-2 IgG(RBD) ELISA Introduction
    • 11.4.4 BD Biosciences Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
    • 11.4.5 BD Biosciences Recent Development
  • 11.5 ZEUS Scientific
    • 11.5.1 ZEUS Scientific Company Details
    • 11.5.2 ZEUS Scientific Business Overview
    • 11.5.3 ZEUS Scientific SARS-CoV-2 IgG(RBD) ELISA Introduction
    • 11.5.4 ZEUS Scientific Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
    • 11.5.5 ZEUS Scientific Recent Development
  • 11.6 Bio-Rad Laboratories
    • 11.6.1 Bio-Rad Laboratories Company Details
    • 11.6.2 Bio-Rad Laboratories Business Overview
    • 11.6.3 Bio-Rad Laboratories SARS-CoV-2 IgG(RBD) ELISA Introduction
    • 11.6.4 Bio-Rad Laboratories Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
    • 11.6.5 Bio-Rad Laboratories Recent Development
  • 11.7 ALPCO
    • 11.7.1 ALPCO Company Details
    • 11.7.2 ALPCO Business Overview
    • 11.7.3 ALPCO SARS-CoV-2 IgG(RBD) ELISA Introduction
    • 11.7.4 ALPCO Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
    • 11.7.5 ALPCO Recent Development
  • 11.8 Enzo Life Sciences
    • 11.8.1 Enzo Life Sciences Company Details
    • 11.8.2 Enzo Life Sciences Business Overview
    • 11.8.3 Enzo Life Sciences SARS-CoV-2 IgG(RBD) ELISA Introduction
    • 11.8.4 Enzo Life Sciences Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
    • 11.8.5 Enzo Life Sciences Recent Development
  • 11.9 BioMérieux
    • 11.9.1 BioMérieux Company Details
    • 11.9.2 BioMérieux Business Overview
    • 11.9.3 BioMérieux SARS-CoV-2 IgG(RBD) ELISA Introduction
    • 11.9.4 BioMérieux Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
    • 11.9.5 BioMérieux Recent Development
  • 11.10 LOEWE Biochemica
    • 11.10.1 LOEWE Biochemica Company Details
    • 11.10.2 LOEWE Biochemica Business Overview
    • 11.10.3 LOEWE Biochemica SARS-CoV-2 IgG(RBD) ELISA Introduction
    • 11.10.4 LOEWE Biochemica Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
    • 11.10.5 LOEWE Biochemica Recent Development
  • 11.11 Shenzhen YHLO Biotech
    • 11.11.1 Shenzhen YHLO Biotech Company Details
    • 11.11.2 Shenzhen YHLO Biotech Business Overview
    • 11.11.3 Shenzhen YHLO Biotech SARS-CoV-2 IgG(RBD) ELISA Introduction
    • 11.11.4 Shenzhen YHLO Biotech Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
    • 11.11.5 Shenzhen YHLO Biotech Recent Development
  • 11.12 LG
    • 11.12.1 LG Company Details
    • 11.12.2 LG Business Overview
    • 11.12.3 LG SARS-CoV-2 IgG(RBD) ELISA Introduction
    • 11.12.4 LG Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
    • 11.12.5 LG Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global SARS-CoV-2 IgG(RBD) ELISA Scope and Market Size
    SARS-CoV-2 IgG(RBD) ELISA market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global SARS-CoV-2 IgG(RBD) ELISA market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    ELISA Sets
    ELISA Kits

    Segment by Application
    Hospital
    Clinic
    Disease control and prevention system

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    R&D Systems
    Thermo Fisher Scientific
    Ortho Clinical Diagnostics
    BD Biosciences
    ZEUS Scientific
    Bio-Rad Laboratories
    ALPCO
    Enzo Life Sciences
    BioMérieux
    LOEWE Biochemica
    Shenzhen YHLO Biotech
    LG


    Summary:
    Get latest Market Research Reports on SARS-CoV-2 IgG(RBD) ELISA. Industry analysis & Market Report on SARS-CoV-2 IgG(RBD) ELISA is a syndicated market report, published as Global SARS-CoV-2 IgG(RBD) ELISA Market Size, Status and Forecast 2021-2027. It is complete Research Study and Industry Analysis of SARS-CoV-2 IgG(RBD) ELISA market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    2,808.00
    4,212.00
    5,616.00
    3,233.10
    4,849.65
    6,466.20
    426,387.00
    639,580.50
    852,774.00
    288,249.00
    432,373.50
    576,498.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report